Il tuo browser è obsoleto

Con un browser aggiornato, l'esperienza di navigazione sul sito Web di Medtronic sarà migliore. Aggiorna il mio browser adesso.

×

Skip to main content

Professionisti del settore sanitario

Hancock™ II and Hancock II Ultra™

Bioprostheses

  • Medtronic Hancock II Ultra Bioprostheses

Overview

The Hancock™ II valve has stood the test of time. First introduced in the 1980s, it has been tested, studied and earned the trust of cardiac surgeons around the world. After dozens of years, and improvements along the way, there are scores of reasons to use this valve with your patients.

INDICATIONS

The Hancock II and Hancock II Ultra™ are for patients who require replacement of their native or prosthetic aortic and/or mitral valves.

Product Details

TESTED, TRUSTED.

More than 30 years delivering consistent performance and clinical results, you can feel confident procedure after procedure.

Tested, Trusted

DURABILITY

Published clinical experience demonstrates impressive long-term performance in all age groups for both the aortic and mitral valve.

Additional factors that may contribute to durability are the following:

  • T6 (sodium dodecyl sulfate) anti-calcification treatment is applied in order to mitigate the absorption of calcium in the leaflets
  • Next generation flexible polymer stent allows for absorption of stress produced during the cardiac cycle
  • Low pressure fixation process minimizes septal muscle shelf allowing for improved hemodynamics

IMPLANTABILITY

Implantability

Our innovative Cinch™ implant system further capitalizes on the valve’s flexible stent to facilitate valve implantation, particularly through a tight sinotubular space. It also:

  • Improves overall visualization
  • Has stent posts that deflect to allow for easier knot tying near the posts in aortic replacements
  • Helps prevent suture looping
  • Facilitates minimally invasive procedures
  • Protects tissue from inadvertent damage

MAXIMUM FLOW

The Hancock II valve is designed to allow the maximum amount of blood to flow through it.3

  • The sewing ring is mounted flush with the inflow edge of the scalloped stent allowing the bioprosthesis to be positioned completely superior to the annulus
  • The internal diameter of the valve aligns with the patient’s annulus allowing for a larger available flow area
  • The valve design allows blood to flow through the annulus encountering only tissue, not obstructive components such as the stent and sewing ring

SUITABILITY FOR FUTURE INTERVENTIONS

Sustainability

Valve dimensions and geometry enable future TAV-in-SAV replacements.

  • Radiopaque annulus ring and stent post markers provide visible, distinct guidelines during TAV-in-SAV procedures
  • MR conditional, non-metallic frame mitigates risk of corrosion between SAV and TAV stent materials
  • Interior-mounted leaflets mitigate potential risk of coronary obstruction

Product Specifications

Hancock™ II Aortic Valve, Model T505

Need image - Hancock II Aortic Valve, Model T505

Order
Number		 Valve Size
(Stent O.D.*
(±0.5 mm)		 Orifice Diameter
(Stent O.D.
(±0.5 mm)		 Suture Ring Diameter
(±1 mm)		 Valve Height
(±0.5 mm)		 Aortic Protrusion
(±0.5 mm)
(A) (B) (C) (D) (E)
T505C221 21 18.5 27.0 15.0 12.0
T505C223 23 20.5 30.0 16.0 13.5
T505C225 25 22.5 33.0 17.5 15.0
T505C227 27 24.0 36.0 18.5 15.5
T505C229 29 26.0 39.0 20.0 16.0

Hancock™ II Mitral Valve, Model T510

Need image - Hancock II Mitral Valve, Model T510

Order
Number		 Valve Size
(Stent O.D.*
(±0.5 mm)		 Orifice Diameter
(Stent O.D.
(±0.5 mm)		 Suture Ring Diameter
(±1 mm)		 Valve Height
(±0.5 mm)		 Aortic Protrusion
(±0.5 mm)
(A) (B) (C) (D) (E)
T510C25 25 22.5 33.0 18.0 13.5
T510C27 27 24.0 35.0 19.0 14.0
T510C29 29 26.0 38.0 20.5 15.5
T510C31 31 28.0 41.0 22.0 17.0
T510C33 33 30.0 43.0 23.0 17.5

Hancock II Ultra™ Aortic Valve, Model T505

Need image - Hancock II Ultra Aortic Valve, Model T505

Order
Number		 Valve Size
(Stent O.D.*
(±0.5 mm)		 Orifice Diameter
(Stent O.D.
(±0.5 mm)		 Suture Ring Diameter
(±1 mm)		 Valve Height
(±0.5 mm)		 Aortic Protrusion
(±0.5 mm)
(A) (B) (C) (D) (E)
T505U221 21 18.5 26.0 15.0 12.0
T505U223 23 20.5 28.0 16.0 13.5
T505U225 25 22.5 30.0 17.5 15.0
T505U227 27 24.0 32.0 18.5 15.5
T505U229 29 26.0 34.0 20.0 16.0
Order Number Description
T7610HKA Tray, Accessory, Hancock II, Aortic
T7605HKM Tray, Accessory, Hancock II, Mitral
T7505UX Tray, Accessory, Hancock II Ultra, Supra-X Aortic Sizer Set
7505UX Hancock II Ultra, Supra-X Aortic Sizer Set
7639 Handle (234 mm length) pilant, without locknut handle to be used with Hancock II, Hancock II Ultra prostheses
7639XL Handle (368 mm length) pilant, without locknut handle to be used with Hancock II, Hancock II Ultra prostheses
7505SET Hancock II Aortic Obturator Set (no handles, no tray)
7510SET Hancock II Mitral Obturator Set (no handles, no tray)
*

Equivalent to annulus diameter

References

1

David T, Armstrong S, Maganti M, Hancock II bioprosthesis for aortic valve replacement: the gold standards of bioprosthetic valves durability? Ann Thorac Surg 2010;90:775–81.

2

Rizzoli G, et al. Fifteen-year results with the Hancock II valve: A multicenter experience. J Thorac Cardiovasc Surg 2006;132:602-9. 

3

Wright JM, et al. Hancock II - An Improved Bioprosthesis. In: Cohn LJ, Galucci V. ed. Cardiac Bioprostheses. New York, NY: York Medical Books, 1982.

Medtronic Italia S.p.A. Società a socio unico soggetta ad attività di direzione e coordinamento da parte di Medtronic PLC.
Cap. soc. € 1.200.487,00 - Codice fiscale, partita IVA e numero di iscrizione al Registro delle Imprese di Milano-Monza-Brianza-Lodi 09238800156 – REA MI – 1275682. Sede Legale e Uffici Via Varesina, 162 Edificio Raimondi - 20156 Milano.